In addition, the higher expression levels of the ERCC1 gene have been linked with poor response of FOLFOX-based chemoradiation in colorectal cancer [48] and with the aggressiveness of esophageal cancer [49]. This evidence concerns the gene ERCC1 and colorectal cancer.